New COVID Jab Gives Hope For The Immunocompromised
A COVID vaccine that provokes an immune response through white blood cells has showed promise in trials, according to research Tuesday that provides new hope for people with compromised immune systems.The jab, known as CoVac-1 and developed by a team at Germany's University of Tuebingen, was shown to produce a strong white blood cell – or T-cell – response in all 36 phase one trial participants.T-cells are white blood cells that attack and neutralise whole infected cells.